The estimated Net Worth of Enterprise Associates 14, L... is at least 17.3 百万$ dollars as of 5 April 2022. Enterprise L owns over 694,551 units of Imara Inc stock worth over 16,501,836$ and over the last 3 years Enterprise sold IMRA stock worth over 750,115$.
Enterprise has made over 1 trades of the Imara Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently Enterprise sold 694,551 units of IMRA stock worth 750,115$ on 5 April 2022.
The largest trade Enterprise's ever made was selling 694,551 units of Imara Inc stock on 5 April 2022 worth over 750,115$. On average, Enterprise trades about 694,551 units every 0 days since 2022. As of 5 April 2022 Enterprise still owns at least 2,611,050 units of Imara Inc stock.
You can see the complete history of Enterprise L stock trades at the bottom of the page.
Over the last 5 years, insiders at Imara Inc have traded over 7,889,059$ worth of Imara Inc stock and bought 11,496,717 units worth 107,874,489$ . The most active insiders traders include David M Mott、Lundbeck A S H、Capital Management, L.P.Ra .... On average, Imara Inc executives and independent directors trade stock every 23 days with the average trade being worth of 1,965,179$. The most recent stock trade was executed by Michael Gray on 22 February 2023, trading 9,856 units of IMRA stock currently worth 46,028$.
Imara Inc. is a clinical-stage biotechnology company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin. Imara is currently advancing IMR-687, a highly selective, potent small molecule inhibitor of PDE9 that is an oral, once-a-day, potentially disease-modifying treatment for sickle cell disease and beta-thalassemia.
Imara Inc executives and other stock owners filed with the SEC include: